# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zelda Fitzgerald (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET004-SYN-TD
- Date: 1930-09-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margot Ellery, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 58300 (insertion of an intrauterine device) and CPT 99497 (advance care planning), all on the same day

## Chief complaint

Periodic adult preventive visit, with contraception. **S**

## History of present illness

Ms. Fitzgerald is a 30-year-old dancer and writer, five weeks after her three-month review, who comes for her yearly preventive visit and to talk again about contraception. Her diagnosis was revised at the last visit to bipolar I disorder with psychotic features, now in full remission, on lithium and aripiprazole. She has had no manic, depressive, or psychotic symptoms since the spring. Her periods have been regular since July. She dances about three and a half hours a day, eats three meals and two snacks as she planned with the dietitian, and has gained a little weight, which she accepts. She sleeps eight hours. At the last visit she learned that lithium can affect a developing baby's heart and that valproate is avoided because of its risks in pregnancy; she does not want a pregnancy for at least two years and would like a long-acting method. She uses condoms with a new partner. Her PHQ-9 today is 3. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 30 |
| Mood and psychosis | No symptoms since the spring; lithium 300 mg twice daily and aripiprazole 10 mg daily |
| Periods | Regular since July |
| Dance and food | About three and a half hours a day; meals and snacks as planned |
| Pregnancy plans | None for at least two years; would like a long-acting method |
| Mood | PHQ-9 3; item 9 scored 0 |

## Health risk assessment

Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Ellery. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Supported by her roommate, her dance class, and the coordinated specialty care team; writing every morning |
| Substance use | AUDIT-C 1; no drugs |
| Tobacco | Never smoked |
| Physical activity | Dance about three and a half hours a day, with one full rest day a week |
| Nutrition | Three meals and two snacks; calcium-rich foods daily; SCOFF 0 of 5 |
| Sleep | About eight hours at regular times |
| Sexual and reproductive health | One new partner; condoms; no pregnancy wanted for at least two years |
| Safety at home | Feels safe; no one hurts, threatens, or controls her; no firearm in the home |
| Road safety | Wears a seat belt |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or fatigue; weight up a little as planned |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No dry mouth or sore throat |
| Cardiovascular | Negative | No chest pain, palpitations, or fainting |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea or diarrhea |
| Genitourinary | Negative | Regular periods; no increased thirst or urination; no discharge or pelvic pain |
| Endocrine | Negative | No heat or cold intolerance; no breast discharge |
| Musculoskeletal | Negative | No stress pain in the feet or shins |
| Integumentary | Negative | No acne flare or rash on lithium |
| Neurological | Negative | Faint fine tremor only when tired; no restlessness or stiffness |
| Psychiatric | Negative | Mood steady; PHQ-9 score 3; no racing thoughts, voices, or thoughts of suicide or self-harm |

12 systems reviewed. **S**

## Current medications

- Lithium carbonate 300 mg oral capsule, one capsule by mouth twice daily **S**
- Aripiprazole 10 mg oral tablet, one tablet by mouth once daily **S**
- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/68 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 51.9 kg; BMI 19.1 kg/m². All vital signs are synthetic.

PHQ-9: 3; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- PHQ-9: 11 at baseline, 3 at this visit **S**
- AUDIT-C: 2 at baseline, 1 at this visit **S**

## Immunizations given today

- Influenza vaccine, 1930-1931 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 51.9 kg, BMI 19.1; blood pressure 108/68 |
| Neck | Thyroid not enlarged; no nodules |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender |
| Pelvic | Normal external genitalia, vagina, and cervix; uterus normal in size and position; no adnexal tenderness. HPV test collected; levonorgestrel intrauterine system placed without difficulty after a negative urine pregnancy test; strings trimmed to 3 cm |
| Skin | No rash or acne |
| Neurological | Very faint fine postural tremor; no rigidity or abnormal movements |
| Psychiatric | Bright, organized, and engaged; no psychotic or manic features |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. A levonorgestrel intrauterine system was placed today at her choice, after counseling: lithium carries a small added risk of heart defects in a baby exposed early in pregnancy, valproate is avoided, and any future pregnancy should be planned with psychiatry. The device does not interact with lithium or aripiprazole. **S**
   - Condoms as well with new partners, for infection protection.
   - Folic acid 0.4 mg daily.
   - Mild cramping expected for a few days; call for fever, severe pain, or if she cannot feel the strings.
   - Next preventive visit in one year.
2. **Bipolar I disorder with psychotic features, in full remission** (F31.74). Remission continues on lithium and aripiprazole. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in her phone, and she has no firearm. She chose to write a psychiatric advance directive today. **S**
   - Continue lithium carbonate 300 mg twice daily and aripiprazole 10 mg daily.
   - Six-month review in six weeks with lithium level, kidney and thyroid tests, and the AIMS.

## Medication changes

- Started: Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 108/68 mmHg |
| Depression screening | Completed today | PHQ-9 score 3, from 11 at intake; item 9 scored 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Eating and exercise screen | Completed today | SCOFF 0 of 5, from 1 at intake; regular periods; dancing about three and a half hours a day with a rest day; BMI 19.1 |
| Cervical cancer screening | Ordered | Last cytology three years ago was normal; primary HPV test collected today, every five years if negative |
| Contraception and pregnancy planning | Completed today | Levonorgestrel intrauterine system placed today; counseled that lithium carries a small added risk of heart defects early in pregnancy, that valproate is avoided because of birth defects and effects on a child's development, and to plan any pregnancy with psychiatry |
| Folic acid | Completed today | 0.4 mg daily started for a person who could become pregnant |
| Intimate partner violence screening | Completed today | Negative; she feels safe |
| HIV and hepatitis C screening | Ordered | No result on record; once-in-a-lifetime tests drawn today with her agreement |
| Chlamydia and gonorrhea screening | Ordered | Offered because of a new partner; urine test today |
| Diabetes and cholesterol screening | Up to date | Not due by age; fasting glucose 86 mg/dL, A1c 5.1% and lipids normal at the 12-week antipsychotic check; yearly while on aripiprazole |
| Influenza vaccine | Completed today | Given today |
| COVID-19 vaccine | Declined | Discussed; she prefers to wait and will reconsider in the winter |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap six years ago |
| HPV vaccine | Up to date | Series completed in adolescence |

## Advance care planning

Voluntary advance care planning discussion of about 18 minutes, with her consent. She chose to complete a psychiatric advance directive: if she becomes ill again, she wants her early warning signs (sleeping less, training for hours, racing thoughts) taken seriously at once, to continue lithium, to avoid valproate, to be treated near home, and to have paper and pencils so she can write. She named a health care agent, recorded in the confidential part of the chart and not named here. She chose not to record other treatment preferences today. The directive will be revisited yearly or after any episode. **S**

## Guideline basis

- U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- HPV, HIV, hepatitis C, and sexual-health results by phone. Six-month review in six weeks with lithium level, creatinine, TSH, and the AIMS. Next preventive visit in one year. **S**
- Next scheduled visit 1930-10-26: six-month review: maintenance treatment, lithium monitoring, and movement check. **S**
